Candida auris: Virulence and antifungal drugs resistance

Invasive fungal infections frequently originate from one of the Candida species. The new species Candida auris, It has a high rate of clinical treatment failure, produces invasive infections, has just been discovered. in contrast to Candida albicans, C. glabrata, C. parapsilosis, and C. tropicalis,...

Full description

Saved in:
Bibliographic Details
Main Authors: Al-Garawi, Noor Al-Houda D., Meri, Marwa Ahmed, Sahib, R. A.
Format: Conference Proceeding
Language:English
Subjects:
Fungicides
Public health
Virulence
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Invasive fungal infections frequently originate from one of the Candida species. The new species Candida auris, It has a high rate of clinical treatment failure, produces invasive infections, has just been discovered. in contrast to Candida albicans, C. glabrata, C. parapsilosis, and C. tropicalis, which species are most frequently associated with the deadly candidiasis. Most closely linked to a few environmental or infrequently seen but widespread Candida species is this emerging pathogen. Additionally, C. auris is currently viewed as a serious hazard to public health due to its fast global proliferation. Over the past few years, C. auris infections and outbreaks have increased in hospital settings. Identification challenges, characteristics of multidrug resistance, development of virulence factors, high patient death rates related with it, and extended life on inert surfaces for longer than two weeks in the environment. In therapeutic settings, C. auris presents significant difficulties.
ISSN:0094-243X
1551-7616
DOI:10.1063/5.0181986